Defining an antigenic epitope on platelet factor 4 associated with heparin-induced thrombocytopenia

Blood

Volumn 92, Issue 9, 1998, Pages 3250-3259

  Ziporen, L ^b   Li, Z Q ^b   Park, K S ^b   Sabnekar, P ^b   Liu, W Y ^b   Arepally, G ^b   Shoenfeld, Y ^b   Kieber Emmons, T ^b   Cines, D B ^b   Poncz, M ^a  

^a CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; HEPARIN; THROMBOCYTE FACTOR 4;

AMINO ACID SUBSTITUTION; ANTIGEN BINDING; ANTIGEN RECOGNITION; ARTICLE; CLINICAL ARTICLE; DRUG PROTEIN BINDING; HUMAN; PATHOGENESIS; POINT MUTATION; PRIORITY JOURNAL; THROMBOCYTOPENIA;

EID: 0032211182     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v92.9.3250     Document Type: Article

References (48)

1. Chong BH: Heparin-induced thrombocytopenia (review). Br J Haematol 89:431, 1995
2. Greinacher A: Antigen generation in heparin-associated thrombocytopenia: The nonimmunologic type and the immunologie type are closely linked in their pathogenesis. Semin Thromb Hemost 21:106, 1995
3. Cines D, Kaywin P, Bina M, Tomaski A, Schreiber AD: Heparin-associated thrombocytopenia. N Engl J Med 303:788, 1980
4. Chong BH, Fawaz I, Chesterman CN, Berndt MC: Heparin-induced thrombocytopenia: Mechanism of interaction of the heparin-dependent antibody with platelets. Br J Haematol 73:235, 1989
5. Warkentin TE, Levine MN, Hirsh J, Horsewood P, Roberts RS, Gent M, Kelton JG: Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin. N Engl J Med 332:1330, 1995
6. Weismann RE, Tobin RW: Arterial embolism occurring during systemic heparin therapy. Arch Surg 76:219, 1958
7. Robert S, Bo FE, Rosato BFE, Rosato EF: Heparin: A cause of arterial emboli? Surgery 55:803, 1964
8. Amiral J, Bridey F, Dreyfus M, Vissac AM, Fressinaud E, Wolf M, Meyer D: Platelet factor 4 complexed to heparin is the target for antibodies generated in heparin-induced thrombocytopenia. Thromb Haemost 68:95, 1992
9. Visentin GP, Ford SE, Scott JP, Aster RH: Antibodies from patients with heparin-induced thrombocytopenia/thrombosis are specific for platelet factor 4 complexed with heparin or bound to endothelial cell. J Clin Invest 93:81, 1994
10. Greinacher A, Potzsch B, Amiral J, Dummel V, Eichner A, Mueller-Eckhardt C: Heparin-associated thrombocytopenia: Isolation of the antibody and characterization of a multimolecular PF4-heparin complex as the major antigen. Thromb Haemost 71:247, 1994
11. Kelton JG, Smith JW, Warkentin TE, Hay ward CPM, Denomme GA, Horsewood P: Heparin-induced thrombocytopenia binds to a complex of heparin and platelet factor 4. Blood 83:3232, 1994
12. Arepally G, Reynolds C, Tornaski A, Amiral J, Jawad A, Poncz M, Cines D: Comparison of PF4/heparin ELISA assay with the 14 C-serotonin release assay in the diagnosis of heparin-induced thrombocytopenia. Am J Clin Pathol 104:648, 1995
13. Kelton JG, Sheridan D, Santos A, Smith J, Steves K, Smith C, Brown C, Murphy WG: Heparin-induced thrombocytopenia: Laboratory studies. Blood 72:925, 1988
14. Anderson GP: Insights into heparin-induced thrombocytopenia. Br J Haematol 80:504, 1992
15. Cines DB, Tomaski A, Tannenbaum S: Immune endothelial-cell injury in heparin-associated thrombocytopenia. N Engl J Med 316:581, 1987
16. Amiral J, Marfaingkoka A, Wolf M, Alessi MC, Tardy B, Boyer-Neumann C, Vissac AM, Fressinaud E, Poncz M, Meyer D: Presence of autoantibodies to interleukin-8 or neutrophil activating peptide-2 in patients with heparin-associated thrombocytopenia. Blood 88:410, 1996
17. Rollins JR: Chemokines. Blood 90:909, 1997
18. Deuel TF, Keim PS, Farmer M, Heinrikson RL: Human platelet factor 4: complete amino acid sequence. Proc Natl Acad Sci USA 74: 2256, 1977
19. Poncz M, Surrey S, LaRocco P, Weiss MJ, Rappaport EF, Conway TM, Schwartz E: Cloning and characterization of platelet factor 4 cDNA derived from a human erythroleukemic cell line. Blood 69:219,1987
20. St Charles R, Walz DA, Edwards BFP: Three dimensional structure of bovine platelet factor 4 at 3.0 A resolution. J Biol Chem 264:2092, 1989
21. Zhang X, Chen L, Bancroft DP: Crystal structure of recombinant human platelet factor Biochemistry 33:8361, 1994
22. Malkowski MG, Wu JY, Lazar JB, Johnson PH, Edwards FP: The crystal structure of recombinant human neutrophil-activating peptide-2 (M6L) at 1.9A resolution. J Biol Chem 270:7077, 1995
23. Mayo KH, Roongta V, Ilyina E, Milius R, Barker S: NMR solution structure of the 32-kDa platelet factor 4 ELR-motif N-terminal chimera: asymmetric tetramer. Biochemistry 34:11399, 1995
24. Mayo KH, Ilyina E, Roongta V, Dundas M, Joseph J, Lai CK, Maione T, Daly TJ: Heparin binding to platelet factor 4. NMR and site-directed mutagenesis study: Arginine residues are crucial for binding. Biochem J 312:357, 1995
25. Stuckey JA, St Charles R, Edwards BFP: A model of the platelet factor 4 complex with heparin. Proteins 14:277, 1992
26. Niewiarowski S: Secreted platelet proteins, in Bloom AL, Thomas DP (eds): Hemostasis and Thrombosis. New York, NY, Churchill Livingstone, 1993, p 167
27. Handin RI, Cohen HJ: Purification and binding properties of human platelet factor four. J Biol Chem 251:4273, 1976
28. Deuel T, Senior R Chang D. Griffin G, Heinrikson R: Platelet factor 4 is chemotactic for neutrophils and monocytes. Proc Natl Acad Sci USA 78:45844, 1981
29. Maione TF, Gray GS, Petro J, Hunt AJ, Donner AL, Bauer SI, Carson AP, Sharp RJ: Inhibition of angiogenesis by recombinant human platelet factor 4 and related peptides. Science 24:77, 1990
30. Gewirtz AM, Calabretta B, Rucinski B, Niewiarowski S, Xu WY: Inhibition of human megakaryocytopoiesis in vitro by platelet factor 4 (PF4) and a synthetic COOH-terminal PF4 peptide. J Clin Invest 83:1477, 1989
31. Zucker MB, Katz IR: Platelet factor 4: Production, structure, and physiologic and immunologie action. Proc Soc Exp Biol Med 198:693, 1991
32. Walz A, Zwahlen R, Baggiolini M: Formation and biological properties of neutrophil activating peptide 2 (NAP-2). Adv Exp Med Biol 305:39, 1991
33. Kungl AJ, Machius M, Huber R, Schwer C, Lam C, Aschauer H, Ehn G, Lindly IJ, Auer M: Purification, crystallization and preliminary X-ray diffraction analysis of recombinant human neutrophil-activating peptide 2 (rhNAP-2). FESB Lett 347:300, 1994
34. Yan Z, Zhang J, Holt JC, Stewart GJ, Niewiarowski S, Poncz M: Structural requirements of platelet chemokines for neutrophil activation. Blood 84:2329, 1994
35. Suh JS, Aster RH, Visentin GP: Antibodies from patients with heparin-induced thrombocytopenia/thrombosis recognize different epitopes onheparin:platelet factor 4. Blood 91:916, 1998
36. Horsewood P, Warkentin TE, Hayward CPM, Kelton JG: The epitope specificity of heparin-induced thrombocytopenia. Br J Haematol 95:161, 1996
37. Chong BH, Newman PM: The antigenic epitope in heparin-induced thrombocytopeni a resides solely on platelet factor 4. Blood 90:2046, 1997 (abstr)
38. Sheridan D, Carter C, Kelton JG: A diagnostic test for heparin-induced thrombocytopenia. Blood 67:27, 1986
39. Park KS, Rifat S, Eck H, Adachi K, Surrey S, Poncz M: Biologic and biochemtc properties of recombinant platelet factor 4 demonstrate identity with the native protein. Blood 75:1290, 1990
40. Block KL, Ravid K, Phung QH, Poncz M: Characterization of regulatory elements in the 5′-flanking region of the rat GPIIb gene by studies in a primary rat marrow culture system. Blood 84:3385, 1994
41. Reichlin M: Use of glutaraldehyde as a coupling agent for proteins and peptides. Methods Enzymol 70:159, 1980
42. Bernstein FC, Koetzle TF, Williams GJB: The protein databank: A computer-based archival file for macromolecular structure. J Mol Biol 112:535, 1977
43. Murali R, Brennan PJ, Kieber-Emmons T, Greene MI: Structural analysis of p 185 (c-neu) and epidermal growth-factor receptor tyrosine kinase: Oligomerization of kinase domains. Proc Natl Acad Sci USA 93:6252, 1996
44. Kahn MJ, Kieber-Emmons T, Vilaire G, Murali R, Poncz M, Bennett JS: Effect of mutagenesis of GPIIb amino acid 273 on the expression and configuration of the platelet integrin GPIIb-IIIa. Biochemistry 35:14304, 1996
45. dark-Lewis I, Geiser T, Moser B,Baggiolini M: Platelet factor 4 binds to interleukin 8 receptors and activates neutrophils when its N-terminus is modified with Glu-Leu-Arg. Proc Natl Acad Sci USA 90:3574, 1993
46. Olson ST, Bjork I, Sheffer R, Craig PA, Shore JD, Choay J: Role of the antithrombin-binding pentasaccharide in heparin acceleration of antithrombin-proteinase reactions. Resolution of the antithrombin conformational change contribution to heparin rate enhancement. J Biol Chem 267:12528, 1992
47. Matsuura E, Igarashi Y, Yasuda T, Koik T, Triplett DA: Anticardiolipin antibodies recognize β-2 glycoprotein I structure altered by interacting with an oxygen modified solid phase surface. J Exp Med 179:457, 1994
48. Pengo V, Biasiolo A, Fior MG: Autoimmune antiphospholipid antibodies are directed against a cryptic epitope expressed when β-2 glycoprotein I is bound to a suitable surface. Thromb Haemost 73:29, 1995